Aarey Drugs & Pharmaceuticals Live BSE/NSE | Aarey Drugs & Pharmaceuticals Fundamenta data | Aarey Drugs & Pharmaceuticals Balance sheet | Aarey Drugs & Pharmaceuticals Quarterly Results | Aarey Drugs & Pharmaceuticals Profit & Loss | Aarey Drugs & Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

66.06
11.79
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

81.85
0.35%
0.69

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

22.53
10.69
-3.60

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.95
42.14
-3.87

PAT CAGR (%)

10 Years
5 Years
3 Years

23.23
43.10
6.14

P:E (Median)

8 Years
5 Years
3 Years

21.53
15.05
10.38

P:BV (Average)

8 Years
5 Years
3 Years

0.59
0.59
0.59

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.02
10.39
6.92

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 49.82 63.56 -21.62% 25.22 66.20 -61.90% 110.68 137.31 -19.39% 59.65 78.44 -23.95%
Expenses 49.50 62.44 -20.72% 23.71 64.94 -63.49% 111.17 134.83 -17.55% 58.33 76.45 -23.70%
EBITDA 0.32 1.12 -71.43% 1.51 1.26 19.84% -0.49 2.48 - 1.31 1.99 -34.17%
EBIDTM 0.64% 1.75% 5.99% 1.91% -0.44% 1.81% 2.20% 2.54%
Other Income 2.55 0.92 177.17% 0.74 1.51 -50.99% 3.42 1.82 87.91% 0.85 0.73 16.44%
Interest 0.80 0.46 73.91% 0.47 0.42 11.90% 0.37 0.66 -43.94% 0.51 0.98 -47.96%
Depreciation 0.22 0.28 -21.43% 0.22 0.25 -12.00% 0.11 0.46 -76.09% 0.25 0.19 31.58%
PBT 1.85 1.30 42.31% 1.56 2.10 -25.71% 2.44 3.18 -23.27% 1.40 1.55 -9.68%
Tax 0.00 0.00 0.00 0.20 0.00 0.00 1.45 2.44 -40.57% 0.00 0.00 0.00
PAT 1.85 1.30 42.31% 1.36 2.10 -35.24% 1.00 0.74 35.14% 1.40 1.55 -9.68%
PATM 3.71% 2.04% 5.39% 3.17% 0.90% 0.54% 2.35% 1.98%
EPS 0.79 0.55 43.64% 0.58 0.90 -35.56% 0.43 0.31 38.71% 0.60 0.66 -9.09%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 245.37 354.71 348.63 395.97 246.03 213.44 199.73 172.31 130.48 67.68 46.50 Net Sales Growth -28.98% 1.74% -11.96% 60.94% 15.27% 6.86% 15.91% 32.06% 92.79% 45.55% Cost Of Goods Sold 236.60 340.97 337.37 382.99 241.99 209.67 194.54 167.84 126.73 64.76 43.94 Gross Profit 8.77 13.73 11.27 12.98 4.03 3.77 5.19 4.46 3.75 2.91 2.56 GP Margin 3.58% 3.87% 3.23% 3.28% 1.64% 1.77% 2.60% 2.59% 2.87% 4.30% 5.51% Total Expenditure 242.71 346.82 340.99 386.36 245.02 212.08 198.40 170.27 128.87 66.21 45.22 Power & Fuel Cost - 0.04 0.04 0.04 0.07 0.03 0.52 0.01 0.06 0.35 0.34 % Of Sales - 0.01% 0.01% 0.01% 0.03% 0.01% 0.26% 0.01% 0.05% 0.52% 0.73% Employee Cost - 0.37 0.35 0.34 0.26 0.26 0.41 0.28 0.26 0.20 0.08 % Of Sales - 0.10% 0.10% 0.09% 0.11% 0.12% 0.21% 0.16% 0.20% 0.30% 0.17% Manufacturing Exp. - 2.04 0.07 0.00 0.77 0.46 0.63 0.41 0.15 0.19 0.16 % Of Sales - 0.58% 0.02% 0% 0.31% 0.22% 0.32% 0.24% 0.11% 0.28% 0.34% General & Admin Exp. - 2.05 1.88 1.47 0.95 0.88 1.07 0.81 1.21 0.30 0.37 % Of Sales - 0.58% 0.54% 0.37% 0.39% 0.41% 0.54% 0.47% 0.93% 0.44% 0.80% Selling & Distn. Exp. - 1.32 1.12 1.43 0.91 0.72 1.11 0.77 0.42 0.39 0.29 % Of Sales - 0.37% 0.32% 0.36% 0.37% 0.34% 0.56% 0.45% 0.32% 0.58% 0.62% Miscellaneous Exp. - 0.03 0.17 0.10 0.07 0.07 0.11 0.14 0.04 0.01 0.29 % Of Sales - 0.01% 0.05% 0.03% 0.03% 0.03% 0.06% 0.08% 0.03% 0.01% 0.09% EBITDA 2.65 7.89 7.64 9.61 1.01 1.36 1.33 2.04 1.61 1.47 1.28 EBITDA Margin 1.08% 2.22% 2.19% 2.43% 0.41% 0.64% 0.67% 1.18% 1.23% 2.17% 2.75% Other Income 7.56 4.34 3.18 3.34 3.14 2.59 1.58 0.20 0.14 0.16 0.14 Interest 2.15 2.23 1.92 4.33 1.72 1.49 0.95 0.76 0.75 0.13 0.00 Depreciation 0.80 1.01 0.71 0.64 0.62 1.05 0.62 0.58 0.59 0.50 0.47 PBT 7.25 8.99 8.19 7.98 1.81 1.41 1.34 0.90 0.41 1.00 0.95 Tax 1.65 2.44 2.01 2.50 0.52 0.32 0.29 0.24 0.13 0.21 0.14 Tax Rate 22.76% 27.14% 24.54% 31.33% 28.73% 22.70% 21.64% 26.67% 31.71% 21.00% 14.74% PAT 5.61 6.54 6.18 5.47 1.29 1.09 1.05 0.66 0.28 0.79 0.81 PAT before Minority Interest 5.61 6.54 6.18 5.47 1.29 1.09 1.05 0.66 0.28 0.79 0.81 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.29% 1.84% 1.77% 1.38% 0.52% 0.51% 0.53% 0.38% 0.21% 1.17% 1.74% PAT Growth -1.41% 5.83% 12.98% 324.03% 18.35% 3.81% 59.09% 135.71% -64.56% -2.47% Unadjusted EPS 2.40 2.79 2.64 2.34 0.55 0.47 0.45 0.28 0.12 0.34 0.35

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

245.37

354.71

348.63

395.97

246.03

213.44

199.73

172.31

130.48

67.68

46.50

Net Sales Growth

-28.98%

1.74%

-11.96%

60.94%

15.27%

6.86%

15.91%

32.06%

92.79%

45.55%

Cost Of Goods Sold

236.60

340.97

337.37

382.99

241.99

209.67

194.54

167.84

126.73

64.76

43.94

Gross Profit

8.77

13.73

11.27

12.98

4.03

3.77

5.19

4.46

3.75

2.91

2.56

GP Margin

3.58%

3.87%

3.23%

3.28%

1.64%

1.77%

2.60%

2.59%

2.87%

4.30%

5.51%

Total Expenditure

242.71

346.82

340.99

386.36

245.02

212.08

198.40

170.27

128.87

66.21

45.22

Power & Fuel Cost

0.04

0.07

0.03

0.52

0.01

0.06

0.35

0.34

% Of Sales

0.01%

0.03%

0.01%

0.26%

0.01%

0.05%

0.52%

0.73%

Employee Cost

0.37

0.35

0.34

0.26

0.41

0.28

0.26

0.20

0.08

% Of Sales

0.10%

0.09%

0.11%

0.12%

0.21%

0.16%

0.20%

0.30%

0.17%

Manufacturing Exp.

2.04

0.07

0.00

0.77

0.46

0.63

0.41

0.15

0.19

0.16

% Of Sales

0.58%

0.02%

0.31%

0.22%

0.32%

0.24%

0.11%

0.28%

0.34%

General & Admin Exp.

2.05

1.88

1.47

0.95

0.88

1.07

0.81

1.21

0.30

0.37

% Of Sales

0.58%

0.54%

0.37%

0.39%

0.41%

0.54%

0.47%

0.93%

0.44%

0.80%

Selling & Distn. Exp.

1.32

1.12

1.43

0.91

0.72

1.11

0.77

0.42

0.39

0.29

% Of Sales

0.37%

0.32%

0.36%

0.37%

0.34%

0.56%

0.45%

0.32%

0.58%

0.62%

Miscellaneous Exp.

0.03

0.17

0.10

0.07

0.11

0.14

0.04

0.01

0.29

% Of Sales

0.01%

0.05%

0.03%

0.06%

0.08%

0.03%

0.01%

0.09%

EBITDA

2.65

7.89

7.64

9.61

1.01

1.36

1.33

2.04

1.61

1.47

1.28

EBITDA Margin

1.08%

2.22%

2.19%

2.43%

0.41%

0.64%

0.67%

1.18%

1.23%

2.17%

2.75%

Other Income

7.56

4.34

3.18

3.34

3.14

2.59

1.58

0.20

0.14

0.16

0.14

Interest

2.15

2.23

1.92

4.33

1.72

1.49

0.95

0.76

0.75

0.13

0.00

Depreciation

0.80

1.01

0.71

0.64

0.62

1.05

0.62

0.58

0.59

0.50

0.47

PBT

7.25

8.99

8.19

7.98

1.81

1.41

1.34

0.90

0.41

1.00

0.95

Tax

1.65

2.44

2.01

2.50

0.52

0.32

0.29

0.24

0.13

0.21

0.14

Tax Rate

22.76%

27.14%

24.54%

31.33%

28.73%

22.70%

21.64%

26.67%

31.71%

21.00%

14.74%

PAT

5.61

6.54

6.18

5.47

1.29

1.09

1.05

0.66

0.28

0.79

0.81

PAT before Minority Interest

5.61

6.54

6.18

5.47

1.29

1.09

1.05

0.66

0.28

0.79

0.81

Minority Interest

0.00

PAT Margin

2.29%

1.84%

1.77%

1.38%

0.52%

0.51%

0.53%

0.38%

0.21%

1.17%

1.74%

PAT Growth

-1.41%

5.83%

12.98%

324.03%

18.35%

3.81%

59.09%

135.71%

-64.56%

-2.47%

Unadjusted EPS

2.40

2.79

2.64

2.34

0.55

0.47

0.45

0.28

0.12

0.34

0.35

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 86.55 80.24 49.19 36.70 35.41 34.52 33.47 32.81 21.91 9.21 Share Capital 23.38 23.38 18.08 16.81 16.81 16.81 16.81 14.01 5.00 5.00 Total Reserves 60.85 54.55 30.07 19.88 18.59 17.71 16.66 18.80 5.00 4.21 Non-Current Liabilities 1.53 1.35 1.61 0.09 0.00 0.01 0.17 0.02 0.04 4.37 Secured Loans 0.04 0.06 0.07 0.09 0.00 0.00 0.00 0.02 0.04 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.01 0.17 0.00 0.00 4.37 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 57.63 88.19 91.70 88.21 79.54 72.35 73.48 54.01 20.72 12.54 Trade Payables 37.28 77.58 74.55 71.95 67.14 64.08 67.73 48.08 15.35 9.71 Other Current Liabilities 0.37 4.26 4.38 0.63 0.28 1.54 0.17 0.66 1.04 2.17 Short Term Borrowings 16.12 3.18 10.32 14.45 11.02 5.70 4.69 4.41 3.25 0.00 Short Term Provisions 3.86 3.18 2.45 1.19 1.09 1.03 0.88 0.86 1.07 0.67 Total Liabilities 145.71 169.78 142.50 125.00 114.95 106.88 107.12 86.84 42.67 26.12 Net Block 12.27 11.71 12.15 7.85 5.89 4.38 4.08 3.94 4.53 3.60 Gross Block 26.13 24.56 24.28 19.35 16.77 14.01 13.08 12.37 12.36 10.93 Accumulated Depreciation 13.86 12.85 12.14 11.50 10.88 9.62 9.00 8.42 7.83 7.33 Non Current Assets 12.72 12.50 12.61 8.29 6.33 5.16 7.64 4.82 5.40 5.28 Capital Work in Progress 0.00 0.34 0.00 0.00 0.00 0.33 0.33 0.88 0.88 1.68 Non Current Investment 0.44 0.44 0.44 0.44 0.44 0.44 3.23 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 Other Non Current Assets 0.01 0.01 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 132.99 157.29 129.88 116.71 108.59 101.66 99.38 81.89 37.24 20.84 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 21.25 14.77 5.21 2.08 4.17 5.13 7.52 8.12 3.48 4.74 Sundry Debtors 105.74 95.30 81.86 72.48 66.71 64.85 66.41 47.80 19.36 13.14 Cash & Bank 0.37 3.39 1.04 1.62 0.17 0.85 0.51 1.14 0.38 0.16 Other Current Assets 5.63 0.11 0.00 0.00 37.53 30.83 24.95 24.82 14.02 2.81 Short Term Loans & Adv. 4.59 43.72 41.78 40.53 37.53 27.34 24.95 24.57 13.86 2.71 Net Current Assets 75.36 69.10 38.18 28.49 29.05 29.31 25.91 27.88 16.52 8.30 Total Assets 145.71 169.79 142.49 125.00 114.95 106.88 107.11 86.84 42.66 26.12

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

86.55

80.24

49.19

36.70

35.41

34.52

33.47

32.81

21.91

9.21

Share Capital

23.38

18.08

16.81

14.01

5.00

Total Reserves

60.85

54.55

30.07

19.88

18.59

17.71

16.66

18.80

5.00

4.21

Non-Current Liabilities

1.53

1.35

1.61

0.09

0.00

0.01

0.17

0.02

0.04

4.37

Secured Loans

0.04

0.06

0.07

0.09

0.00

0.02

0.04

0.00

Unsecured Loans

0.00

0.01

0.17

0.00

4.37

Long Term Provisions

0.00

Current Liabilities

57.63

88.19

91.70

88.21

79.54

72.35

73.48

54.01

20.72

12.54

Trade Payables

37.28

77.58

74.55

71.95

67.14

64.08

67.73

48.08

15.35

9.71

Other Current Liabilities

0.37

4.26

4.38

0.63

0.28

1.54

0.17

0.66

1.04

2.17

Short Term Borrowings

16.12

3.18

10.32

14.45

11.02

5.70

4.69

4.41

3.25

0.00

Short Term Provisions

3.86

3.18

2.45

1.19

1.09

1.03

0.88

0.86

1.07

0.67

Total Liabilities

145.71

169.78

142.50

125.00

114.95

106.88

107.12

86.84

42.67

26.12

Net Block

12.27

11.71

12.15

7.85

5.89

4.38

4.08

3.94

4.53

3.60

Gross Block

26.13

24.56

24.28

19.35

16.77

14.01

13.08

12.37

12.36

10.93

Accumulated Depreciation

13.86

12.85

12.14

11.50

10.88

9.62

9.00

8.42

7.83

7.33

Non Current Assets

12.72

12.50

12.61

8.29

6.33

5.16

7.64

4.82

5.40

5.28

Capital Work in Progress

0.00

0.34

0.00

0.33

0.88

1.68

Non Current Investment

0.44

3.23

0.00

Long Term Loans & Adv.

0.00

0.01

0.00

Other Non Current Assets

0.01

0.03

0.00

Current Assets

132.99

157.29

129.88

116.71

108.59

101.66

99.38

81.89

37.24

20.84

Current Investments

0.00

Inventories

21.25

14.77

5.21

2.08

4.17

5.13

7.52

8.12

3.48

4.74

Sundry Debtors

105.74

95.30

81.86

72.48

66.71

64.85

66.41

47.80

19.36

13.14

Cash & Bank

0.37

3.39

1.04

1.62

0.17

0.85

0.51

1.14

0.38

0.16

Other Current Assets

5.63

0.11

0.00

37.53

30.83

24.95

24.82

14.02

2.81

Short Term Loans & Adv.

4.59

43.72

41.78

40.53

37.53

27.34

24.95

24.57

13.86

2.71

Net Current Assets

75.36

69.10

38.18

28.49

29.05

29.31

25.91

27.88

16.52

8.30

Total Assets

145.71

169.79

142.49

125.00

114.95

106.88

107.11

86.84

42.66

26.12

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 0.69 -20.35 0.62 5.66 3.25 -0.42 3.37 -8.98 -10.97 -1.18 PBT 8.99 8.19 7.98 1.81 1.41 1.34 0.90 0.41 1.00 0.95 Adjustment 3.24 2.63 5.02 2.37 2.57 1.60 1.37 1.34 0.64 0.47 Changes in Working Capital -9.29 -28.56 -10.27 1.48 -0.73 -3.36 1.10 -10.73 -12.60 -2.46 Cash after chg. in Working capital 2.94 -17.74 2.72 5.66 3.25 -0.42 3.37 -8.98 -10.97 -1.04 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.25 -2.61 -2.10 0.00 0.00 0.00 0.00 0.00 0.00 -0.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.23 -0.60 -4.96 -2.58 -2.43 1.86 -3.39 -0.01 -0.63 -1.92 Net Fixed Assets -1.23 -0.62 -4.93 -2.58 -2.43 -0.93 -0.16 -0.01 -0.63 -8.32 Net Investments 0.00 0.00 0.00 0.00 0.00 2.79 -3.23 0.00 0.00 0.00 Others 0.00 0.02 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 6.40 Cash from Financing Activity -2.48 23.31 3.75 -1.63 -1.50 -1.10 -0.61 9.75 11.82 2.87 Net Cash Inflow / Outflow -3.02 2.35 -0.58 1.45 -0.68 0.34 -0.63 0.76 0.22 -0.23 Opening Cash & Equivalents 3.39 1.04 1.62 0.00 0.85 0.51 1.14 0.38 0.16 0.40 Closing Cash & Equivalent 0.37 3.39 1.04 1.62 0.17 0.85 0.51 1.14 0.38 0.16

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

0.69

-20.35

0.62

5.66

3.25

-0.42

3.37

-8.98

-10.97

-1.18

PBT

8.99

8.19

7.98

1.81

1.41

1.34

0.90

0.41

1.00

0.95

Adjustment

3.24

2.63

5.02

2.37

2.57

1.60

1.37

1.34

0.64

0.47

Changes in Working Capital

-9.29

-28.56

-10.27

1.48

-0.73

-3.36

1.10

-10.73

-12.60

-2.46

Cash after chg. in Working capital

2.94

-17.74

2.72

5.66

3.25

-0.42

3.37

-8.98

-10.97

-1.04

Interest Paid

0.00

Tax Paid

-2.25

-2.61

-2.10

0.00

-0.14

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-1.23

-0.60

-4.96

-2.58

-2.43

1.86

-3.39

-0.01

-0.63

-1.92

Net Fixed Assets

-1.23

-0.62

-4.93

-2.58

-2.43

-0.93

-0.16

-0.01

-0.63

-8.32

Net Investments

0.00

2.79

-3.23

0.00

Others

0.00

0.02

-0.03

0.00

6.40

Cash from Financing Activity

-2.48

23.31

3.75

-1.63

-1.50

-1.10

-0.61

9.75

11.82

2.87

Net Cash Inflow / Outflow

-3.02

2.35

-0.58

1.45

-0.68

0.34

-0.63

0.76

0.22

-0.23

Opening Cash & Equivalents

3.39

1.04

1.62

0.00

0.85

0.51

1.14

0.38

0.16

0.40

Closing Cash & Equivalent

0.37

3.39

1.04

1.62

0.17

0.85

0.51

1.14

0.38

0.16

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 36.02 33.33 26.63 21.82 21.04 20.49 19.85 19.44 21.47 19.81 ROA 4.15% 3.96% 4.09% 1.07% 0.98% 0.98% 0.68% 0.44% 2.30% 3.90% ROE 8.07% 9.80% 12.90% 3.58% 3.12% 3.10% 1.99% 1.33% 8.24% 9.21% ROCE 12.05% 14.14% 22.21% 7.23% 6.69% 5.83% 4.42% 3.72% 5.83% 8.13% Fixed Asset Turnover 14.00 14.30 18.15 13.62 13.87 14.75 13.54 10.56 5.81 6.34 Receivable days 103.43 92.55 71.13 103.25 112.49 119.94 120.96 93.94 87.64 83.08 Inventory Days 18.53 10.44 3.36 4.63 7.95 11.56 16.57 16.23 22.16 30.40 Payable days 59.49 79.48 68.80 104.65 113.37 119.67 0.00 87.13 70.19 56.90 Cash Conversion Cycle 62.47 23.51 5.69 3.23 7.07 11.83 137.53 23.04 39.61 56.58 Total Debt/Equity 0.19 0.04 0.22 0.40 0.31 0.17 0.15 0.14 0.33 0.48 Interest Cover 5.03 5.27 2.84 2.06 1.95 2.42 2.18 1.55 8.55 581.87

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

36.02

33.33

26.63

21.82

21.04

20.49

19.85

19.44

21.47

19.81

ROA

4.15%

3.96%

4.09%

1.07%

0.98%

0.68%

0.44%

2.30%

3.90%

ROE

8.07%

9.80%

12.90%

3.58%

3.12%

3.10%

1.99%

1.33%

8.24%

9.21%

ROCE

12.05%

14.14%

22.21%

7.23%

6.69%

5.83%

4.42%

3.72%

5.83%

8.13%

Fixed Asset Turnover

14.00

14.30

18.15

13.62

13.87

14.75

13.54

10.56

5.81

6.34

Receivable days

103.43

92.55

71.13

103.25

112.49

119.94

120.96

93.94

87.64

83.08

Inventory Days

18.53

10.44

3.36

4.63

7.95

11.56

16.57

16.23

22.16

30.40

Payable days

59.49

79.48

68.80

104.65

113.37

119.67

0.00

87.13

70.19

56.90

Cash Conversion Cycle

62.47

23.51

5.69

3.23

7.07

11.83

137.53

23.04

39.61

56.58

Total Debt/Equity

0.19

0.04

0.22

0.40

0.31

0.17

0.15

0.14

0.33

0.48

Interest Cover

5.03

5.27

2.84

2.06

1.95

2.42

2.18

1.55

8.55

581.87

Aarey Drugs & Pharmaceuticals Ltd.

Trading

BSE: 524412 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Aarey Drugs & Pharmaceuticals Ltd.

Trading

BSE: 524412 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update